Early-stage thymic carcinoma: is adjuvant therapy required?

Although the prognosis of advanced thymic carconoma remains poor, previous reports have shown survival rates of 70% to 100% in patients with Masaoka stage I or stage II of the disease who were treated with surgery followed by adjuvant therapy. However, the role of adjuvant therapy in these stages is...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Sakai, Mitsuaki, Onuki, Takuya, Inagaki, Masaharu, Yamaoka, Masatoshi, Kitazawa, Shinsuke, Kobayashi, Keisuke, Iguchi, Kesato, Kikuchi, Shinji, Goto, Yukinobu, Onizuka, Masataka, Sato, Yukio
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Pioneer Bioscience Publishing Company 2013
Gaiak:
Brief Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3621945/
https://ncbi.nlm.nih.gov/pubmed/23585943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2013.01.06
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak